Who invested in MyoKardia?
MyoKardia's investors include Cormorant Asset Management, Casdin Capital, Third Rock Ventures, Cowen Group and BridgeBio, and 1 more on record.
United States · Series B startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow MyoKardia and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$98Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $46M sold, first sale Apr 2015
No investor was named in the report.
From a historical funding recordSEC filing: $10M sold, first sale Aug 2014
No investor was named in the report.
Reported by sec.govSEC filing: $4.0M sold, first sale Sept 2012
Reported by finsmes.comSEC filing: $4.0M sold, first sale Sept 2012
From the SEC filings it signed: 1 on the team.
On the board, as filediCharles HomcyKatherine BowdishKevin StarrMark Perry
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MyoKardia's investors include Cormorant Asset Management, Casdin Capital, Third Rock Ventures, Cowen Group and BridgeBio, and 1 more on record.
MyoKardia has raised $98M across 4 rounds since 2012.
MyoKardia's most recent round was a Series B of $46M in Apr 2015.
Its most recent round, $46M in Apr 2015, is also its largest on record.
MyoKardia's first round on record, in Sept 2012, was backed by Third Rock Ventures.
MyoKardia's latest named round is a Series B, in Apr 2015.
MyoKardia is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.